Aethlon Medical
AEMD
6 hedge funds and large institutions have $437K invested in Aethlon Medical in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
14% less funds holding
Funds holding: 7 → 6 (-1)
49% less capital invested
Capital invested by funds: $851K → $437K (-$414K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$25.9K |
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$56K |
| 2 |
BlackRock
New York
|
-$51.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51.7K |
| 4 |
BC
Bartlett & Co
Cincinnati,
Ohio
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $157K | -$51.7K | -2 | -25% |
|
|
2
BlackRock
New York
| $112K | -$51.7K | -2 | -33% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $51K | – | – | – |
|
|
4
Creative Planning
Overland Park,
Kansas
| $41K | +$25.9K | +1 | +100% |
|
5
Northern Trust
Chicago,
Illinois
| $36K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $14K | – | – | – |
|
7
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $11K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $8K | – | – | – |
|
|
DADC
9
D.A. Davidson & Co
Great Falls,
Montana
| $3K | – | – | – |
|
|
PMFA
10
Plante Moran Financial Advisors
Southfield,
Michigan
| $2K | – | – | – |
|
|
AG
11
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
12
Morgan Stanley
New York
| $1K | – | – | – |
|
|
13
Bank of New York Mellon
New York
| – | -$56K | -1 | Closed |
|
|
BC
14
Bartlett & Co
Cincinnati,
Ohio
| – | -$13K | – | – |
|
AEMD Hedge Fund Activity: Q2 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2017, worth a combined $437K — down 49% from $851K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AEMD and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Creative Planning, adding an estimated $25.9K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $56K sold.
- 6 institutional investors held Aethlon Medical (AEMD) as of Q2 2017, down from 7 in Q1 2017.
- Funds reported $437K of Aethlon Medical stock for Q2 2017, down 49% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest Aethlon Medical buyer in Q2 2017 was Creative Planning, an estimated $25.9K added.
- The largest Aethlon Medical seller in Q2 2017 was Bank of New York Mellon, an estimated $56K sold.
Based on aggregated 13F filings for Q2 2017.